126 related articles for article (PubMed ID: 35950410)
1. Investigating and modeling the differential DNA methylation for early lung adenocarcinoma diagnosis.
Shi X; Feng T; Xu Y; Wu X; Shao Y; Liang Z
Biomark Med; 2022 Sep; 16(13):947-958. PubMed ID: 35950410
[No Abstract] [Full Text] [Related]
2. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
Li M; Zhang C; Zhou L; Li S; Cao YJ; Wang L; Xiang R; Shi Y; Piao Y
Mol Oncol; 2020 Nov; 14(11):2744-2758. PubMed ID: 32688456
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
5. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma.
Daugaard I; Dominguez D; Kjeldsen TE; Kristensen LS; Hager H; Wojdacz TK; Hansen LL
Sci Rep; 2016 Oct; 6():35807. PubMed ID: 27782156
[TBL] [Abstract][Full Text] [Related]
7. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
[TBL] [Abstract][Full Text] [Related]
8. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
9. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
[TBL] [Abstract][Full Text] [Related]
10. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer.
Wei B; Wu F; Xing W; Sun H; Yan C; Zhao C; Wang D; Chen X; Chen Y; Li M; Ma J
Sci Rep; 2021 Aug; 11(1):16782. PubMed ID: 34408226
[TBL] [Abstract][Full Text] [Related]
11. Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers.
Hu S; Tao J; Peng M; Ye Z; Chen Z; Chen H; Yu H; Wang B; Fan JB; Ni B
Biomark Res; 2023 Apr; 11(1):45. PubMed ID: 37101220
[TBL] [Abstract][Full Text] [Related]
12. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.
Wang Q; Wu L; Yu J; Li G; Zhang P; Wang H; Shao L; Liu J; Shen W
BMC Med Genomics; 2022 Mar; 15(1):66. PubMed ID: 35313869
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
15. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Shi S; Xu M; Xi Y
Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory Study.
Kim-Wanner SZ; Assenov Y; Nair MB; Weichenhan D; Benner A; Becker N; Landwehr K; Kuner R; Sültmann H; Esteller M; Koch I; Lindner M; Meister M; Thomas M; Bieg M; Klingmüller U; Schlesner M; Warth A; Brors B; Seifried E; Bönig H; Plass C; Risch A; Muley T
J Thorac Oncol; 2020 Aug; 15(8):1338-1350. PubMed ID: 32272161
[TBL] [Abstract][Full Text] [Related]
18. Long-read sequencing unveils novel somatic variants and methylation patterns in the genetic information system of early lung cancer.
Cui X; Lin Q; Chen M; Wang Y; Wang Y; Wang Y; Tao J; Yin H; Zhao T
Comput Biol Med; 2024 Mar; 171():108174. PubMed ID: 38442557
[TBL] [Abstract][Full Text] [Related]
19. Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer.
Roncarati R; Lupini L; Miotto E; Saccenti E; Mascetti S; Morandi L; Bassi C; Rasio D; Callegari E; Conti V; Rinaldi R; Lanza G; Gafà R; Papi A; Frassoldati A; Sabbioni S; Ravenna F; Casoni GL; Negrini M
Mol Oncol; 2020 Sep; 14(9):2163-2175. PubMed ID: 32441866
[TBL] [Abstract][Full Text] [Related]
20. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
Ke H; Wu Y; Wang R; Wu X
Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
